Dejia Li
- Molecular Biology top 5%
- Cancer Research top 1%
- Genetics top 10%
- Physiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Topics
- Circular RNAs in diseases (17 papers)MicroRNA in disease regulation (15 papers)Cancer-related molecular mechanisms research (14 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Dejia Li
65 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 132
- Molecular Biology 2.3k
- Cancer Research 1.4k
- Genetics 280
- Physiology 268
- Cardiology and Cardiovascular Medicine 227
Countries citing papers authored by Dejia Li
This map shows the geographic impact of Dejia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejia Li more than expected).
Fields of papers citing papers by Dejia Li
This network shows the impact of papers produced by Dejia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejia Li. The network helps show where Dejia Li may publish in the future.
Co-authorship network of co-authors of Dejia Li
This figure shows the co-authorship network connecting the top 25 collaborators of Dejia Li. A scholar is included among the top collaborators of Dejia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dejia Li. Dejia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 91 | |
| 8 | 18 | |
| 9 | 6 | |
| 10 | 168 | |
| 11 | 8 | |
| 12 | 18 | |
| 13 | 93 | |
| 14 | 20 | |
| 15 | 16 | |
| 16 | 55 | |
| 17 | 37 | |
| 18 | 295 | |
| 19 | 23 | |
| 20 | 9 |
About Dejia Li
Dejia Li is a scholar working on Cancer Research, Rehabilitation and Health, Toxicology and Mutagenesis, having authored 65 papers that have together received 3.0k indexed citations. Recurring topics across this work include Circular RNAs in diseases (17 papers), MicroRNA in disease regulation (15 papers) and Cancer-related molecular mechanisms research (14 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.3k citations) and Rehabilitation (117 citations). Dejia Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Cheng‐Cao Sun, Shujun Li, Dongsheng Duan, Feng Zhang, Yongyong Xi, Yongping Yue, Liang Wang, Yi Lai, Qi‐qiang He and Yongyi Bi. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.